-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Although the urban medical consortium is relatively loose, it is the main battlefield of the future medical service market.
Since the medical insurance reform will continue, especially the centralized procurement of medicines and consumables has played a role in the bottom line of hospital income, and the DRG payment model will lead to the transparency of medical service prices, which externally forces large hospitals to obtain more disease sources to make up for it.
Furthermore, the growth of tertiary hospitals has not only squeezed lower-level hospitals and grassroots, but also has a clear impact on private hospitals.
However, from a numerical point of view, despite the siphon of tertiary hospitals, the community health centers in the urban medical union are the only ones that benefit.
As the proportion of tertiary hospitals in the market continues to expand, medical expenses are growing rapidly.
From the perspective of the cost structure, due to the impact of the assessment of the proportion of drugs, the hospital’s drug revenue has shown a negative growth, mainly relying on inspections, services and consumables to make up for and obtain revenue growth.
Therefore, under continuous internal and external pressure, the development of the urban medical consortium will accelerate its expansion in the entire market, mainly squeezing medical institutions outside the medical consortium, and extending its antennae to the county medical community, continuing to siphon the entire area.